(S)-Methyl 1-methyl-5-oxopyrrolidine-2-carboxylate

Catalog No. :
ACTVLM309
CAS No. :
42435-88-1
Molecular Formula :
C7H11NO3
Molecular Weight :
157.17

IUPAC Name:methyl (S)-1-methyl-5-oxopyrrolidine-2-carboxylate

(S)-Methyl 1-methyl-5-oxopyrrolidine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$99.00Login to see priceIn stockInquiry
5g95%$381.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-Methyl 1-methyl-5-oxopyrrolidine-2-carboxylate
IUPAC Namemethyl (S)-1-methyl-5-oxopyrrolidine-2-carboxylate
MDL No.MFCD12026427
Molecular FormulaC7H11NO3
Molecular Weight157.17
SMILESO=C([C@H](CC1)N(C)C1=O)OC
InChI KeyABAOXDQXQHQRFA-YFKPBYRVSA-N
SynonymL-Proline, 1-methyl-5-oxo-, methyl ester (9CI);1-Methyl-5-oxo-L-proline methyl ester;1-Methyl-L-pyroglutamic acid methyl ester;Me-pGlu-Ome;(S)-Methyl-1-Methyl-5-Oxopyrrolidine-2- Carboxylate;L-Proline, 1-methyl-5-oxo-, methyl ester;L-Proline, 1-methyl-5-oxo-, methyl ester (9CI) USP/EP/BP;methyl (2S)-1-methyl-5-oxopyrrolidine-2-carboxylate
CAS No.42435-88-1
PubChem CID12361160

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACTVLM309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNBLD012 route compound structure diagram
    ACNBLD0124931-66-2 In Stock
  4. Then
  5. ACTVLM309 route product structure diagram
    ACTVLM30942435-88-1 In Stock
Inquiry

2. ACTVLM309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSTX691 route compound structure diagram
    ACCSTX69128874-51-3 In Stock
  2. Then
  3. ACTVLM309 route product structure diagram
    ACTVLM30942435-88-1 In Stock
Inquiry

Comments (0)